SCHEMBL1664489

SCHEMBL1664489

O=C(O)C1=CC2=CC=CCC2=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2721543 0.86
SCHEMBL31392785 0.80 KDM4E (0.30)
SCHEMBL27799963 0.71
SCHEMBL7843318 0.70
SCHEMBL7746085 0.70 SLC7A5 (0.36)
SCHEMBL7746093 0.70 SLC7A5 (0.36)
SCHEMBL6204258 0.70
SCHEMBL1133633 0.69
SCHEMBL28797310 0.68 HCAR3 (0.32)
SCHEMBL12514244 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024072930-A1 DOPAMINE D3/D2 RECEPTOR PARTIAL AGONISTS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-04-04 WO disclosed
EP-3362754-A1 PROTEASOME INHIBITORS AND USES THEREOF Cornell University (US) 2018-08-22 EP disclosed
WO-2017066763-A1 PROTEASOME INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2017-04-20 WO disclosed
WO-2011041593-A1 NOVOBIOCIN ANALOGUES AND TREATMENT OF POLYCYSTIC KIDNEY DISEASE UNIVERSITY OF KANSAS (US) 2011-04-07 WO disclosed
WO-2008072257-A2 PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES IND-SWIFT LABORATORIES LIMITED (IN) 2008-06-19 WO disclosed
EP-1682530-A1 SUBSTITUTED PYRROLE-INDOLES AS INHIBITORS OF PAI-1 Wyeth (US) 2006-07-26 EP disclosed
WO-2005030756-A1 SUBSTITUTED PYRROLE-INDOLES AS INHIBITORS OF PAI-1 WYETH (US) 2005-04-07 WO disclosed